| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/05/2004 | US20040152098 Cellular signal-responsive gene transcriptional regulation system |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040151938 Supplying to human or animals; into brain, tissues, lungs; coils, spring |
| 08/05/2004 | US20040151789 Herbal compositions for the treatment of mucosal lesions |
| 08/05/2004 | US20040151776 Novel compositions |
| 08/05/2004 | US20040151739 transporter and fusion protein contains a binding domain for the transporter and a modulation domain for the covalent modification of small GTP-binding proteins; transporter permits the uptake of the fusion protein in a target cell |
| 08/05/2004 | US20040151713 Cell cycle regulatory factor |
| 08/05/2004 | US20040151692 administering a substance that can activate CD163 to stimulate the growth, proliferation, differentiation and/or mobilization of a stem cell, e.g., a substance that binds CD163 includes antibodies and CD163 ligands. |
| 08/05/2004 | US20040151687 Poly(diallylamine)-based bile acid sequestrants |
| 08/05/2004 | US20040151667 Internal image antibodies for optical imaging and therapy |
| 08/05/2004 | CA2514153A1 Antibody and use thereof |
| 08/05/2004 | CA2514108A1 Drugs containing galectin 9 |
| 08/05/2004 | CA2513606A1 Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia |
| 08/05/2004 | CA2513170A1 Skeletal muscle protecting agent |
| 08/05/2004 | CA2509456A1 Substituted alkyl amido piperidines |
| 08/04/2004 | EP1443438A1 Dna providing system |
| 08/04/2004 | EP1443108A2 Processes for preparing reconstructed skin supplemented in ceramid 7 and/or 5.5, composition based on lamellar lipid vesicles comprising a derivative of ceramid 7 and/or 5.5 and use thereof |
| 08/04/2004 | EP1443046A1 Novel 4-(2furoyl)aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 08/04/2004 | EP1442743A1 Medicament comprising alpha-lipoic acid, ambroxol and/or inhibitors of the angiotensin converting enzyme (ACE) for use in the treatment of neurodegenerative diseases |
| 08/04/2004 | EP1442742A1 Apoptosis inducer and method of screening for a substance inhibiting acylated homoserine lactone |
| 08/04/2004 | EP1442115A2 METHODS OF ISOLATION, EXPANSION AND DIFFERENTIATION OF FETAL STEM CELLS FROM CHORIONIC VILLUS, AMNIOTIC FLUID, AND PLACENTA AND THERAPEUTIC USES THEREOF |
| 08/04/2004 | EP1442064A2 Kinases and phosphatases |
| 08/04/2004 | EP1442060A2 A novel g protein-coupled receptor, gave 10 |
| 08/04/2004 | EP1442050A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/04/2004 | EP1442049A2 Substituted amino ketone compounds |
| 08/04/2004 | EP1442042A1 Polycyclic guanine derivative phosphodiesterase v inhibitors |
| 08/04/2004 | EP1442039A1 Pyrimido (4,5-b) indole derivatives |
| 08/04/2004 | EP1442037A1 Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands |
| 08/04/2004 | EP1442036A2 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 |
| 08/04/2004 | EP1442035A1 Process for the preparation of 4- (8-chloro-5, 6-dihydro-11h-benzo-[5,6]-cyclohepta-[1,2-b]-pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine) |
| 08/04/2004 | EP1442034A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
| 08/04/2004 | EP1442025A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 08/04/2004 | EP1442024A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS |
| 08/04/2004 | EP1442023A1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 08/04/2004 | EP1442022A2 Polyamide modulators of cox2 transcription |
| 08/04/2004 | EP1442020A1 Heterocyclic derivatives of glycinamide and their medical use |
| 08/04/2004 | EP1442019A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 08/04/2004 | EP1442017A1 Preparation of benzosuberonylpiperidine compounds |
| 08/04/2004 | EP1442016A1 1h-indole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 08/04/2004 | EP1442008A1 Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 08/04/2004 | EP1441772A2 Polymer conjugates of protein kinase c inhibitors |
| 08/04/2004 | EP1441767A1 Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment |
| 08/04/2004 | EP1441765A2 Method for preparation of single chain antibodies |
| 08/04/2004 | EP1441762A1 Rsv gene expression vaccine |
| 08/04/2004 | EP1441756A1 Psp-94: use for treatment of hypercalcemia and bone metastasis |
| 08/04/2004 | EP1441752A1 Endophilin homologous proteins involved in the regulation of energy homeostasis |
| 08/04/2004 | EP1441751A1 TARGETING THE REVERSE MODE OF THE Na+ /Ca2+ EXCHANGER FOR THE TREATMENT OF OPTIC NEUROPATHY ASSOCIATED WITH GLAUCOMA AND ISCHEMIC OPTIC NEUROPATHY |
| 08/04/2004 | EP1441743A2 Methods for treating ocular neovascular diseases |
| 08/04/2004 | EP1441738A1 A combination product comprising melagatran and dexamethasone |
| 08/04/2004 | EP1441737A1 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity |
| 08/04/2004 | EP1441735A1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 08/04/2004 | EP1441734A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 08/04/2004 | EP1441733A1 Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs |
| 08/04/2004 | EP1441732A2 Thiazole derivative and pharmaceutical use thereof |
| 08/04/2004 | EP1441729A1 Piperazine bis-amide derivatives and their use as antagonists of the orexin receptor |
| 08/04/2004 | EP1441728A2 Modulators of the cholesterol biosynthetic pathway |
| 08/04/2004 | EP1441726A1 Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors |
| 08/04/2004 | EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 08/04/2004 | EP1441721A2 Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 08/04/2004 | EP1441720A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system |
| 08/04/2004 | EP1441718A2 Carbinols for the treatment of neuropathic dysfunction |
| 08/04/2004 | EP1441717A1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog |
| 08/04/2004 | EP1441716A1 Alkane diol derivatives as therapeutic agents for the treatment of bone conditions |
| 08/04/2004 | EP1441715A1 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 08/04/2004 | EP1441714A2 Combinations comprising a selective cyclooxygenase-2 inhibitor |
| 08/04/2004 | EP1441711A1 Treatment of breast cancer |
| 08/04/2004 | EP1441710A1 Use of n,n-diethyl-2- -4-(phenylmethyl)-phenoxy ethanamine monohydrochloride (dppe) in cancer therapy |
| 08/04/2004 | EP1441707A1 Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder |
| 08/04/2004 | EP1441706A2 Antimuscarinic aerosol |
| 08/04/2004 | EP1441701A1 Montelukast granule formulation |
| 08/04/2004 | EP1441697A2 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 08/04/2004 | EP1441635A2 Sterile, breathable patch for treating wound pain |
| 08/04/2004 | EP1401275A4 Antiviral composition and treatment method |
| 08/04/2004 | EP1370148A4 Anticholesterolemic edible oil |
| 08/04/2004 | EP1337528B1 Benzothiophene derivative compounds, process of preparation and use thereof |
| 08/04/2004 | EP1313772B1 New cross-linked derivatives of hyaluronic acid |
| 08/04/2004 | EP1296945B1 Sulfonamide derivatives |
| 08/04/2004 | EP1294380B1 A method for treating septic shock |
| 08/04/2004 | EP1278750B1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 08/04/2004 | EP1200444B1 Novel xanthone compounds, their preparation and use as medicament |
| 08/04/2004 | EP1192131B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives |
| 08/04/2004 | EP1171151A4 Thrombospondin-2 and uses thereof |
| 08/04/2004 | EP1169054B1 Prognosis of ptp lar related diseases |
| 08/04/2004 | EP1157001B1 Oxamic acids and derivatives as thyroid receptor ligands |
| 08/04/2004 | EP1150658B1 Method for controlling liposome size |
| 08/04/2004 | EP1124829B1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 08/04/2004 | EP1112262B1 Substituted gamma-phenyl-delta-lactones and analogs thereof and uses related thereto |
| 08/04/2004 | EP1091956B1 Muscarinic antagonists |
| 08/04/2004 | EP1077957B1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 08/04/2004 | EP1076657B1 New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same |
| 08/04/2004 | EP1071745B1 Process for synthesizing cox-2 inhibitors |
| 08/04/2004 | EP1064256B1 Bicyclo [2.2.1] heptanes and related compounds |
| 08/04/2004 | EP1034001B1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |
| 08/04/2004 | EP0961618B1 5-Pyrimidinyl-4-yl-Imidazole Derivate zur Behandlung von CSBP/RK/p38 vermittelten Erkrankungen |
| 08/04/2004 | EP0934531B1 Diagnosis of spongiform encephalopathy |
| 08/04/2004 | EP0873051B1 Modulation of calcium channels |
| 08/04/2004 | CN1518598A Serpin in Bifidobacteria |
| 08/04/2004 | CN1518592A Male contraceptives |
| 08/04/2004 | CN1518553A Beta-substituted befa-aminoethyl. phosphonates compound |
| 08/04/2004 | CN1518552A Pyrrolopyrimidines as protein kinase inhitibors |